Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Herman GA, Stein PP, Thornberry NA, Wagner JA
This is not a dosing guide, and the research product is not for human use
From 2023 to 2025, MedStar Health served as a research site for the ATTAIN-1 trial, a phase III double-blind, placebo-controlled study of the safety and efficacy of the GLP-1 receptor agonist drug orforglipron
Access and coverage remain challenges as newer liver-related indications emerge
From there, we built the MVP and stress-tested it in real-world conditions, continuously refining it through tight development cycles and rigorous QA
US$ 28.69
US$ 24.53
US$ 21.69
US$ 21.17
US$ 22.79
